Cabio Biotech (Wuhan) Market Cap

Cabio Biotech (Wuhan) has a market cap or net worth of 4.38 billion as of June 2, 2025. Its market cap has increased by 110.60% in one year.

Market Cap

4.38B

Enterprise Value

4.24B

Revenue

594.54M

Ranking

n/a

PE Ratio

29.84

Stock Price

26.03

Market Cap Chart

Since December 19, 2019, Cabio Biotech (Wuhan)'s market cap has decreased from 5.54B to 4.38B, a decrease of -20.92%. That is a compound annual growth rate of -4.22%.

Market Cap History

Date	Market Cap	% Change
May 30, 2025	4.38B	36.78%
Dec 31, 2024	3.20B	6.31%
Dec 29, 2023	3.01B	-44.60%
Dec 30, 2022	5.44B	-26.24%
Dec 31, 2021	7.37B	55.15%
Dec 31, 2020	4.75B	6.39%
Dec 31, 2019	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Jiangsu Hengrui Medicine	362.72B
Shenzhen Mindray Bio-Medical Electronics	273.17B
WuXi AppTec	181.57B
Zhangzhou Pientzehuang Pharmaceutical.,	123.11B
Sichuan Biokin Pharmaceutical	120.77B
Aier Eye Hospital Group	115.34B
Shanghai United Imaging Healthcare	112.70B
Yunnan Baiyao Group Co.,Ltd	100.78B

Market Cap Rankings